https://orcid.org/0000-0002-3340-1287
Overview
cancer pharmacogenomics
drug induced neuropathy, neutropenia and hypertension
statistical genetics
statistical methods for high-dimensional data
copulas
survival analysis
statistical computing
drug induced neuropathy, neutropenia and hypertension
statistical genetics
statistical methods for high-dimensional data
copulas
survival analysis
statistical computing
Current Appointments & Affiliations
Professor of Biostatistics & Bioinformatics
·
2021 - Present
Biostatistics & Bioinformatics, Division of Integrative Genomics,
Biostatistics & Bioinformatics
Director, DCI Bioinformatics
·
2013 - Present
Biostatistics & Bioinformatics, Division of Biostatistics,
Biostatistics & Bioinformatics
Member of the Duke Cancer Institute
·
2013 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Spatial proteomics of breast ductal carcinoma in situ reveal distinct regional differences.
Journal Article Sci Rep · March 13, 2026 UNLABELLED: Breast ductal carcinoma in situ is a common non-invasive clinical finding that can progress to invasive breast cancer (IBC). Spatial proteomics can provide an additional dimension to our understanding of this disease and its capacity to progres ... Full text Link to item CiteA rhesus macaque model of congenital cytomegalovirus infection reveals a spectrum of vertical transmission outcomes.
Journal Article Commun Biol · November 24, 2025 Congenital cytomegalovirus (cCMV) is the leading infectious cause of birth defects worldwide, yet immune determinants of protection to inform maternal vaccine design remain elusive due to the lack of a translational animal model. Here, we characterized the ... Full text Link to item CiteCorrection: Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.
Journal Article Breast Cancer Res · August 26, 2025 Full text Link to item CiteRecent Grants
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2031Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET), for low-risk DCIS - clinical follow-up
ResearchBiostatistician · Awarded by Department of Defense · 2026 - 2030From bench to bedside: a multifaceted integrated approach to improve head and neck cancer outcomes.
ResearchBioinformatics Specialist · Awarded by National Institute of Dental and Craniofacial Research · 2024 - 2029View All Grants
Education
University of North Carolina, Chapel Hill ·
2002
Ph.D.